Escalquens, France

Claudine Serradeil-Le Gal


 

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 243(Granted Patents)


Location History:

  • Escalquens, FR (1996 - 2011)
  • Antony, FR (2008 - 2011)
  • Paris, FR (2012 - 2013)

Company Filing History:


Years Active: 1996-2013

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Claudine Serradeil-Le Gal: Innovator in Therapeutic Compounds

Introduction: Claudine Serradeil-Le Gal is a prominent inventor based in Escalquens, France. With an impressive portfolio of 21 patents, Serradeil-Le Gal has made significant contributions to the field of medicinal chemistry. Her work focuses on the development of novel compounds with therapeutic applications, particularly in relation to human arginine-vasopressin receptors.

Latest Patents: Among her latest innovations, Serradeil-Le Gal has developed 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives. This invention pertains to novel compounds that exhibit a strong affinity and high selectivity for human arginine-vasopressin (AVP) V receptors. The therapeutic application of these compounds underscores their potential in treating various health conditions. The specifications include complex structures where variables are defined to denote a variety of chemical groups, highlighting the advanced nature of her research.

Career Highlights: Claudine Serradeil-Le Gal has had a distinguished career, working with major companies such as Sanofi-Aventis and Sanofi-Synthelabo. Her experience in these renowned institutions has greatly contributed to her expertise in the pharmaceutical industry, leading to multiple innovative patents that are recognized in the scientific community.

Collaborations: Throughout her career, Serradeil-Le Gal has collaborated with several notable professionals, including Jean Wagnon and Gerard Valette. These collaborations have enriched her research and facilitated the development of significant therapeutic compounds that have applications in various medical fields.

Conclusion: Claudine Serradeil-Le Gal's contributions to the world of innovation and therapeutic inventions are commendable. With a robust portfolio of patents and valuable collaborations, she continues to influence the pharmaceutical industry, paving the way for advancements that could significantly enhance human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…